Foreign-Trade Zone (FTZ) 61-San Juan, Puerto Rico; Notification of Proposed Production Activity, Boehringer Ingelheim Animal Health Puerto Rico LLC, (Pharmaceutical Products/Canine), Barceloneta, Puerto Rico, 78045 [2022-27690]

Download as PDF Federal Register / Vol. 87, No. 244 / Wednesday, December 21, 2022 / Notices subject to antidumping/countervailing duty (AD/CVD) orders if imported from certain countries. The Board’s regulations (15 CFR 400.14(e)) require that merchandise subject to AD/CVD orders, or items which would be otherwise subject to suspension of liquidation under AD/CVD procedures if they entered U.S. customs territory, be admitted to the zone in privileged foreign (PF) status (19 CFR 146.41). The request also indicates that certain materials/components are subject to duties under Section 232 of the Trade Expansion Act of 1962 (Section 232) or Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 232 and Section 301 decisions require subject merchandise to be admitted to FTZs in PF status. Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is January 30, 2023. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: December 15, 2022. Andrew McGilvray, Executive Secretary. BILLING CODE 3510–DS–P [C–570–094] Refillable Stainless Steel Kegs From the People’s Republic of China: Preliminary Results of Countervailing Duty Administrative Review, Rescission of Review in Part; 2020 DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–61–2022] Foreign-Trade Zone (FTZ) 61—San Juan, Puerto Rico; Notification of Proposed Production Activity, Boehringer Ingelheim Animal Health Puerto Rico LLC, (Pharmaceutical Products/Canine), Barceloneta, Puerto Rico lotter on DSK11XQN23PROD with NOTICES1 [FR Doc. 2022–27690 Filed 12–20–22; 8:45 am] International Trade Administration BILLING CODE 3510–DS–P Boehringer Ingelheim Animal Health Puerto Rico LLC submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Barceloneta, Puerto Rico within Subzone 61AC. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on December 13, 2022. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits 19:56 Dec 20, 2022 Dated: December 15, 2022. Andrew McGilvray, Executive Secretary. DEPARTMENT OF COMMERCE [FR Doc. 2022–27691 Filed 12–20–22; 8:45 am] VerDate Sep<11>2014 that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product(s) would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed finished products include medicament that treats fleas and ticks in finished (packaged) and semifinished (unpackaged) chewable tablets for canines (duty rate is duty-free). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is January 30, 2023. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Juanita Chen at juanita.chen@trade.gov. Jkt 259001 Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The U.S. Department of Commerce (Commerce) preliminarily determines that certain producers/ exporters of refillable stainless steel kegs (kegs) from the People’s Republic of China (China) received countervailable subsidies during the period of review (POR) from January 1, 2020, through December 31, 2020. In addition, we are rescinding the review with respect to 35 companies. Interested parties are invited to comment on these preliminary results. DATES: Applicable December 21, 2022. FOR FURTHER INFORMATION CONTACT: Theodore Pearson, AD/CVD Operations, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 AGENCY: PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 78045 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–2631. Background On February 4, 2022, Commerce published the notice of initiation of an administrative review of the countervailing duty (CVD) order on kegs from China.1 On August 1, 2022, Commerce extended the deadline for the preliminary results of this administrative review by 105 days, until December 16, 2022.2 For a complete description of the events that followed the initiation of this review, see the Preliminary Decision Memorandum.3 A list of topics discussed in the Preliminary Decision Memorandum is included as the appendix to this notice. The Preliminary Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance’s Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). ACCESS is available to registered users at https:// access.trade.gov. In addition, a complete version of the Preliminary Decision Memorandum can be accessed directly at https://access.trade.gov/public/ FRNoticesListLayout.aspx. Scope of the Order The products covered by the order are kegs. For a complete description of the scope, see the Preliminary Decision Memorandum.4 Methodology Commerce is conducting this administrative review in accordance with section 751(a)(1)(A) of the Tariff Act of 1930, as amended (the Act). For each subsidy program found countervailable, we preliminarily find that there is a subsidy, (i.e., a government-provided financial contribution that gives rise to a benefit to the recipient, and that the subsidy is specific).5 For a full description of the methodology underlying our 1 See Initiation of Antidumping and Countervailing Duty Administrative Reviews, 87 FR 6487 (February 4, 2022) (Initiation Notice). 2 See Memorandum, ‘‘Extension of Deadline for Preliminary Results of Countervailing Duty Administrative Review; 2020,’’ dated August 1, 2022. 3 See Memorandum, ‘‘Decision Memorandum for the Preliminary Results of Countervailing Duty Administrative Review, Rescission of Review in Part, 2020: Refillable Stainless Steel Kegs from the People’s Republic of China,’’ dated concurrently with, and hereby adopted by, this notice (Preliminary Decision Memorandum). 4 See Preliminary Decision Memorandum. 5 See sections 771(5)(B) and (D) of the Act regarding financial contribution; section 771(5)(E) of the Act regarding benefit; and section 771(5A) of the Act regarding specificity. E:\FR\FM\21DEN1.SGM 21DEN1

Agencies

[Federal Register Volume 87, Number 244 (Wednesday, December 21, 2022)]
[Notices]
[Page 78045]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27690]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-61-2022]


Foreign-Trade Zone (FTZ) 61--San Juan, Puerto Rico; Notification 
of Proposed Production Activity, Boehringer Ingelheim Animal Health 
Puerto Rico LLC, (Pharmaceutical Products/Canine), Barceloneta, Puerto 
Rico

    Boehringer Ingelheim Animal Health Puerto Rico LLC submitted a 
notification of proposed production activity to the FTZ Board (the 
Board) for its facility in Barceloneta, Puerto Rico within Subzone 
61AC. The notification conforming to the requirements of the Board's 
regulations (15 CFR 400.22) was received on December 13, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific finished product(s) described in the submitted 
notification (summarized below) and subsequently authorized by the 
Board. The benefits that may stem from conducting production activity 
under FTZ procedures are explained in the background section of the 
Board's website--accessible via www.trade.gov/ftz. The proposed 
finished product(s) would be added to the production authority that the 
Board previously approved for the operation, as reflected on the 
Board's website.
    The proposed finished products include medicament that treats fleas 
and ticks in finished (packaged) and semi-finished (unpackaged) 
chewable tablets for canines (duty rate is duty-free).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is January 30, 
2023.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Juanita Chen at 
[email protected].

    Dated: December 15, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-27690 Filed 12-20-22; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.